Indication
Variegate porphyria
Variegate porphyria is a rare autosomal dominant acute hepatic porphyria caused by heterozygous pathogenic variants in the *PPOX* gene, leading to partial deficiency of the mitochondrial enzyme protoporphyrinogen oxidase. Read more about Variegate porphyria
2 drugs 2 manufacturers
Drugs that treat it
Common Variegate porphyria therapies.
PANHEMATIN (hemin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVariegate porphyria is a rare autosomal dominant acute hepatic porphyria caused by heterozygous pathogenic variants in the *PPOX* gene, leading to partial deficiency of the mitochondrial enzyme protoporphyrinogen oxidase.
This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the systemic accumulation and increased excretion of photoreactive porphyrins and neurotoxic porphyrin precursors.
It characteristically manifests after puberty with cutaneous lesions, acute neurovisceral attacks, or a combination of both.
Defining cutaneous findings include sun-induced skin fragility, erosions, blistering bullae, and scarring, while acute neurovisceral episodes present with severe abdominal pain, peripheral neuropathy, autonomic dysfunction, and neuropsychiatric disturbances often triggered by specific medications, fasting, or hormonal shifts.
- porphyriafoundation.org
Variegate porphyria is a rare autosomal dominant acute hepatic porphyria caused by heterozygous pathogenic variants in the *PPOX* gene, leading to partial deficiency of the mitochondrial enzyme protoporphyrinogen oxidase This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the systemic accumulation and increased excretion of photoreactive porphyrins and neurotoxic porphyrin precursors Defining cutaneous findings include sun-induced skin fragility, erosions, blistering bulla...
- news-medical.net
Variegate porphyria is a rare autosomal dominant acute hepatic porphyria caused by heterozygous pathogenic variants in the *PPOX* gene, leading to partial deficiency of the mitochondrial enzyme protoporphyrinogen oxidase This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the systemic accumulation and increased excretion of photoreactive porphyrins and neurotoxic porphyrin precursors
- nova.edu
This enzymatic defect disrupts the heme biosynthetic pathway, resulting in the systemic accumulation and increased excretion of photoreactive porphyrins and neurotoxic porphyrin precursors
- porphyria.org
It characteristically manifests after puberty with cutaneous lesions, acute neurovisceral attacks, or a combination of both Defining cutaneous findings include sun-induced skin fragility, erosions, blistering bullae, and scarring, while acute neurovisceral episodes present with severe abdominal pain, peripheral neuropathy, autonomic dysfunction, and neuropsychiatric disturbances often triggered by specific medications, fasting, or hormonal shifts
- dermnetnz.org
It characteristically manifests after puberty with cutaneous lesions, acute neurovisceral attacks, or a combination of both
Personalize your experience
Follow Variegate porphyria and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.